Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
Crescent Biopharma has raised $185.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Crescent Biopharma's investors include Balyasny Asset Management, Wellington Management, Perceptive Advisors, Blackstone Group, RTW Investments.
Crescent Biopharma is headquartered in Rockville, United States.
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
Crescent Biopharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Crescent Biopharma — Funding & Investors." VCBacked, December 4, 2025, https://www.vcbacked.co/company/crescent-biopharma. Accessed November 12, 2026.
VCBacked. (2025). Crescent Biopharma — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/crescent-biopharma
{{cite web |title=Crescent Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/crescent-biopharma |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Crescent Biopharma? Request a listing update